IP Library Patent Application 17286846
Patent Application
App. No. 17/286,846

TAMPER EVIDENT TRANSDERMAL PATCH

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/286,846
Abstract

Transdermal patch having at least one pharmaceutically active ingredient and a tamper-evidencing element, as well as methods of making and using the same.

Claims (26)

1 . A patch comprising:

one or more active pharmaceutical ingredients;

at least one tamper-evidencing element having a first state and a second state, the tamper-evidencing element being configured to change from the first state to the second state upon exposure to at least one type of tampering; and

at least one antenna having one or more electronically readable features, wherein the electronically readable feature is able to provide a first readout associated with the first state of the tamper-evidencing element and at least a second readout associated with the second state of the tamper-evidencing element, wherein the second readout is differentiable from the first readout.

2 . The patch of claim 1 , wherein the patch comprises at least one active pharmaceutical ingredient layer on a substrate having at least one backing layer opposite the active pharmaceutical ingredient layer; wherein

the tamper-evidencing element is disposed between the at least one backing layer and the at least one active pharmaceutical ingredient layer.

3 . The patch of claim 1 , wherein the patch comprises at least one active pharmaceutical ingredient layer comprising at least one active pharmaceutical ingredient and the tamper-evidencing element.

4 . The patch of claim 1 , further comprising a circuit that is electronically connected to the antenna, the circuit comprising a transponder chip for storing and transmitting at least one piece of information.

5 . The patch of claim 4 , wherein at least one piece of information is a first electronically readable feature when the tamper-evidencing element is in the first state and a second piece of information when the tamper-evidencing element is in the second state.

6 . The patch of claim 4 , wherein the at least one piece of information is either (1) associated with the identity of the patch; (2) associated with the identity of a patient to whom the patch is prescribed; or (3) associated with both the identity of the patch and the identity of a patient to whom the patch is prescribed.

7 . The patch of claim 1 , wherein the antenna is a near-field antenna.

8 . The patch of claim 1 , wherein the patch further comprises at least one microneedle protruding from a first major surface of the patch.

9 . The patch of claim 1 , wherein the patch further comprises at least one skin-contact adhesive disposed thereon.

10 . The patch of claim 1 , wherein the tamper-evidencing element is a dissolvable or degradable element.

11 . The patch of claim 1 , wherein the tamper-evidencing element is a swellable element.

12 . The patch of claim 4 , wherein the resistance or impedance of the circuit changes by at least a factor of 5 when the tamper-evidencing element is contacted by a solvent, wherein the solvent is optionally water or a water alcohol mixture.

13 . The patch of claim 4 , wherein the circuit includes at least one analog to digital converter.

14 . The patch of claim 1 , wherein the tamper-evidencing element is a component of the antenna.

15 . The patch of claim 1 , comprising at least two tamper-evidencing elements.

16 . The patch of claim 1 , further comprising a sensing integrated circuit for sensing patient information or patch information.

17 . The patch of claim 1 , wherein the at least one pharmaceutically active ingredient is an opioid pharmaceutical.

18 . The patch of claim 1 , wherein the opioid pharmaceutical is fentanyl.

19 . A method of determining whether a patch was exposed to one or more tampering conditions, comprising:

reading one or more of the at least one electrically readable features of the patch of claim 1 ; and

determining whether the readout provided by the patch is the first readout or the second readout.

20 . The method of claim 19 , wherein the step of reading one or more of the at least one electrically readable features of the patch comprises receiving a near-field electronic signal from the patch.

Assignments (1)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →